Clinical Trials Directory

Trials / Sponsors / Amylyx Pharmaceuticals Inc.

Amylyx Pharmaceuticals Inc.

Industry · 12 registered clinical trials — 1 currently recruiting.

StatusTrialPhaseStarted
Active Not RecruitingAvexitide for Treatment of Post-Bariatric Hypoglycemia
Post Bariatric Hypoglycemia
Phase 32025-04-29
RecruitingAMX0114 in Adult Participants With Amyotrophic Lateral Sclerosis
ALS
Phase 12025-04-07
Active Not RecruitingAMX0035 and Progressive Supranuclear Palsy
Progressive Supranuclear Palsy, PSP, Neurodegenerative Diseases
Phase 2 / Phase 32023-12-21
Active Not RecruitingAMX0035 in Adult Patients With Wolfram Syndrome
Wolfram Syndrome
Phase 22023-03-03
CompletedExtension Study Evaluating The Safety And Tolerability of AMX0035
Amyotrophic Lateral Sclerosis
Phase 32022-12-29
Active Not RecruitingPhase III Trial of AMX0035 for Amyotrophic Lateral Sclerosis Treatment
Amyotrophic Lateral Sclerosis
Phase 32021-10-28
UnknownPharmacokinetic and Pharmacodynamic Study of AMX0035 in Patients With ALS
ALS
Phase 1 / Phase 22021-08-05
CompletedA Compassionate Use Protocol of AMX0035 for Treatment of Patients With Amyotrophic Lateral Sclerosis (ALS)
Amyotrophic Lateral Sclerosis
Phase 2 / Phase 32020-11-22
CompletedStudy to Assess the Safety and Biological Activity of AMX0035 for the Treatment of Alzheimer's Disease
Alzheimer Disease
Phase 22018-09-14
CompletedOpen Label Extension Study of AMX0035 in Patients With ALS
Amyotrophic Lateral Sclerosis, ALS
Phase 22018-03-29
CompletedAMX0035 in Patients With Amyotrophic Lateral Sclerosis (ALS)
Amyotrophic Lateral Sclerosis, Motor Neuron Disease, Neuromuscular Diseases
Phase 22017-06-22
Approved For MarketingAn Intermediate Size Expanded Access Protocol of AMX0035 for ALS
Amyotrophic Lateral Sclerosis
——